This site is intended for healthcare professionals

1.5 CME Credits

Advances in Cardiovascular Disease Management

Hereditary transthyretin amyloidosis (hATTR) is a rare, inherited condition that can affect multiple organs. It occurs when mutations in the transthyretin (TTR) gene destabilize the protein, causing it to misfold and form amyloid deposits. These deposits gradually damage tissues, leading to serious complications. Over 130 pathogenic variants have been identified, each associated with different symptoms and disease patterns.

Accreditation

Accredited by the Accreditation Council for Continuing Medical Education (ACCME)

Activity ID: CME-2026-CV-001

Faculty

Dr. Sarah Martinez, MD, FACC

Director of Cardiovascular Research, University Medical Center

Dr. James Chen, MD, PhD

Professor of Cardiology, Harvard Medical School

Learning Objectives

  • • Identify the latest evidence-based guidelines for managing patients with heart failure
  • • Evaluate the role of novel anticoagulation therapies in atrial fibrillation management
  • • Apply risk stratification tools to optimize cardiovascular disease prevention strategies
  • • Recognize key pharmacological updates in lipid management and diabetes care

Completion Requirements

  • • Watch educational video (minimum 80% completion required)
  • • Complete all assessment questions
  • • Achieve a passing score of 70% or higher
  • • Provide participant information for certificate